PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Authors
Keywords
Breast cancer, Paclitaxel, PAM50 subtypes, PAM50 proliferation score, Prediction of paclitaxel efficacy
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 138, Issue 2, Pages 457-466
Publisher
Springer Nature
Online
2013-02-19
DOI
10.1007/s10549-013-2416-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples
- (2011) Fathi Elloumi et al. BMC Medical Genomics
- Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
- (2011) M. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Practical implications of gene-expression-based assays for breast oncologists
- (2011) Aleix Prat et al. Nature Reviews Clinical Oncology
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer
- (2010) Sherry X. Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
- (2009) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- Taxanes in the Adjuvant Treatment of Early Breast Cancer, Emerging Consensus and Unanswered Questions
- (2009) Shou-Ching Tang CANCER INVESTIGATION
- Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial
- (2009) Lajos Pusztai et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
- (2009) Judith Hugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Class III -Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel
- (2008) C. M. Galmarini et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
- (2008) M. Martin et al. JNCI-Journal of the National Cancer Institute
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
- (2007) E. Azambuja et al. ANNALS OF ONCOLOGY
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search